Literature DB >> 10724041

Adeno-associated virus vectors show variable dependence on divalent cations for thermostability: implications for purification and handling.

A E Turnbull1, A Skulimowski, J A Smythe, I E Alexander.   

Abstract

Recombinant adeno-associated virus (rAAV) shows significant promise as a vector for gene transfer in pre-clinical models of human disease, and is currently being evaluated in human clinical trials. As a consequence, increasing attention is being turned to the important tasks of optimizing rAAV titer, purity, and stability. We have observed dramatic variation in divalent cation dependence for thermostability of different rAAV vectors. To further investigate this observation, the thermostability of eight different vector constructs ranging in size from 73 to 107% of wild-type genome size (4.68 kilobases) was determined in the presence and absence of divalent cations. Virions containing smaller genomes (i.e., <85% wild type) were relatively divalent cation independent for thermostability. In contrast, virions containing recombinant genomes close to, or exceeding, wild-type size (i.e., >95% wild type) were dependent on divalent cations for thermostability. Genome sequence also appeared to be a factor in the thermostability of the larger rAAV vectors. These observations are of both practical and theoretical significance. Divalent cations should be included in all buffer solutions used during rAAV purification and storage, and unnecessary heat exposure avoided. These data also demonstrate that different recombinants of a particular virus should not be assumed to possess the same thermostability profile.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10724041     DOI: 10.1089/10430340050015815

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  5 in total

1.  Stability and compatibility of recombinant adeno-associated virus under conditions commonly encountered in human gene therapy trials.

Authors:  Alisha M Gruntman; Lin Su; Qin Su; Guangping Gao; Christian Mueller; Terence R Flotte
Journal:  Hum Gene Ther Methods       Date:  2015-04       Impact factor: 2.396

2.  Ultracentrifugation-free chromatography-mediated large-scale purification of recombinant adeno-associated virus serotype 1 (rAAV1).

Authors:  Taro Tomono; Yukihiko Hirai; Hironori Okada; Kumi Adachi; Akiko Ishii; Takashi Shimada; Masafumi Onodera; Akira Tamaoka; Takashi Okada
Journal:  Mol Ther Methods Clin Dev       Date:  2016-02-10       Impact factor: 6.698

Review 3.  Pharmacology of Recombinant Adeno-associated Virus Production.

Authors:  Magalie Penaud-Budloo; Achille François; Nathalie Clément; Eduard Ayuso
Journal:  Mol Ther Methods Clin Dev       Date:  2018-01-08       Impact factor: 6.698

Review 4.  Developments in the formulation and delivery of spray dried vaccines.

Authors:  Gaurav Kanojia; Rimko Ten Have; Peter C Soema; Henderik Frijlink; Jean-Pierre Amorij; Gideon Kersten
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

5.  Parvovirus B19 Uncoating Occurs in the Cytoplasm without Capsid Disassembly and It Is Facilitated by Depletion of Capsid-Associated Divalent Cations.

Authors:  Oliver Caliaro; Andrea Marti; Nico Ruprecht; Remo Leisi; Suriyasri Subramanian; Susan Hafenstein; Carlos Ros
Journal:  Viruses       Date:  2019-05-10       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.